HU Bo-yang, JIANG Dao-feng, WANG Zhang, et al. Study on Characteristics of Goto-kakizaki Diabetes Prone Rat-a Spontaneous Type 2 Diabetes Mellitus Rat Model[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(10): 203-207.
HU Bo-yang, JIANG Dao-feng, WANG Zhang, et al. Study on Characteristics of Goto-kakizaki Diabetes Prone Rat-a Spontaneous Type 2 Diabetes Mellitus Rat Model[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(10): 203-207. DOI: 10.11653/syfj2013100203.
Objective: To study the characteristics of Goto-Kakizaki(GK) diabetes prone rat-a spontaneous type 2 diabetes mellitusanimal model. Method: Twenty Wistar rats were as a control
the based glucose
body weight
food and water intake of GK rats in 61 rats were monitored continuously since thirteen weeks. At the age of thirty-second weeks
a glucose tolerance test was conducted
stool routine
liver index and kidney index were screened
the content of lipid
renal function and glycosylated hemoglobin (HbA1c) in plasma were tested as well as a pathological examination of pancreas and kidney was carried out. Result: At the age of twenty-four weeks
GK rats are at the start of the pathogenesis
and the plasma glucose remained steady at more than 11.0 mmol·L-1 high blood glucose levels
and the HbA1c level were also significantly elevated. These indicators could remain at least till the age of thirty-second weeks. At the same time
GK rats also demonstrate symptoms similar to those of the diabetes patients such as 'emaciation'
'overeating'
'excessive drinking of water' and the rest. The mortality rate of GK rats was relatively low
being only about at 11.47%. GK rats to glucose load were in a reduced metabolic capacity
and the pathological changes of pancreas and liver tissue were aggravated. Conclusion: At the age of 24 to 32 weeks
GK rats were in the period of the pathogenesis
with the obvious and stable characteristics of diabetes
and the mortality rate is low. Therefore
GK rats can be suitable for the research of pathogenesis and drug effectiveness evaluation for diabetes.